MHRA
- Local brand name: Bronchitol
- Status: approved
🇬🇧 Mannitol in United Kingdom
NICE has issued 1 UK HTA decision
Marketing authorisation
Health technology assessment
1 decision from NICE for Mannitol in United Kingdom.
NICE TA266 — ✓ Recommended
- Indication assessed: inhalation for treating cystic fibrosis
NICE recommended Mannitol for treating cystic fibrosis via inhalation. This decision was made without a reported cost-effectiveness analysis or a Patient Access Scheme. No commercial arrangement or restriction was applied.
Mannitol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United Kingdom
Frequently asked questions
Is Mannitol approved in United Kingdom?
Yes. MHRA has authorised it.
Who is the marketing authorisation holder for Mannitol in United Kingdom?
Baxter is the originator. The local marketing authorisation holder may differ — check the official source linked above.
Has Mannitol been assessed by UK health technology agencies?
Yes — 1 UK HTA decision on record from NICE.